Abstract
India’s diagnostics business valued at USD 10 billion was growing at 20% annually. Several players with different business models competed. Dr. Lal PathLabs, the world’s largest histopathology centre led with a menu of 3,500 tests, 1,600 collection centres and 7,000 pick-up points. Its Initial Public Offer had been oversubscribed 33.41 times and the team at Dr. Lal PathLabs was excited about expanding its international footprint. Two overseas companies were incorporated in Netherlands and Nepal. Yet, there were enormous unmet needs in India alongside potential for public-private partnerships. Trade-offs over portfolio choice and regional versus international footprint needed thinking through.
Additional Information
| Product Type | Case |
|---|---|
| Reference No. | BP0408(B) |
| Title | Dr. Lal Pathlabs (B) |
| Pages | 21 |
| Published on | Dec 20, 2017 |
| Year of Event | 2005 |
| Authors | Mathur, Ajeet; |
| Area | Strategy (STR) |
| Discipline | International Business, Strategic Management |
| Sector | Health |
| Keywords | Family Business; Growth Strategy; Dilation of Ownership; Brand Building; Logistics; International Business |
| Country | India; Netherlands; Nepal |
| Organization | Dr. Lal PathLabs |
| Access | For All |
My Cart
You have no items
in your shopping cart.